Androgen deprivation promotes intratumoral synthesis of dihydrotestosterone from androgen metabolites in prostate cancer

Fumio Ishizaki, Tsutomu Nishiyama, Takashi Kawasaki, +5

Scientific Reports

Estrogen receptor alpha drives proliferation in PTEN-deficient prostate carcinoma by stimulating survival signaling, MYC expression and altering glucose sensitivity

Itsuhiro Takizawa, Mitchell G. Lawrence, Preetika Balanathan, +13

Oncotarget

Primary solitary fibrous tumor (SFT) in the retroperitoneum

Itsuhiro Takizawa, Toshihiro Saito, Yasuo Kitamura, +4

Urologic Oncology Seminars and Original Investigations

FibrosisSurgical OncologyTumoral PathologySurgical PathologyHistopathology +3

Translational offsetting as a mode of estrogen receptor α‐dependent regulation of gene expression

Julie Lorent, Eric Kusnadi, Vincent van Hoef, +20

The EMBO Journal

Transcriptional RegulationSystems BiologyTranslational BiologyEndocrine MechanismTranslational Offsetting +7

Serum prostate‐specific antigen levels reflect the androgen milieu in patients with localized prostate cancer receiving androgen deprivation therapy: Tumor malignant potential and androgen milieu

Itsuhiro Takizawa, Tsutomu Nishiyama, Noboru Hara, +3

The Prostate

Oncological results, functional outcomes and health-related quality-of-life in men who received a radical prostatectomy or external beam radiation therapy for localized prostate cancer: a study on long-term patient outcome with risk stratification

Itsuhiro Takizawa, Noboru Hara, Tsutomu Nishiyama, +4

Asian Journal of Andrology

Quality Of LifeUrologySurgical OncologyBiochemical RecurrenceRadiation Therapy +12

Decline of the Red Blood Cell Count in Patients Receiving Androgen Deprivation Therapy for Localized Prostate Cancer: Impact of ADT on Insulin-like Growth Factor-1 and Erythropoiesis

Noboru Hara, Tsutomu Nishiyama, Itsuhiro Takizawa, +3

Urology

UrologyMedicineLocalized Prostate CancerInsulin-like Growth Factor-1Prostatic Disease +3

Prediction of pathological and oncological outcomes based on extended prostate biopsy results in patients with prostate cancer receiving radical prostatectomy: a single institution study

Fumio Ishizaki, Noboru Hara, Hiroshi Koike, +6

Diagnostic Pathology

Trilostane, an inhibitor of 3β-hydroxysteroid dehydrogenase, has an agonistic activity on androgen receptor in human prostate cancer cells

Itsuhiro Takizawa, Tsutomu Nishiyama, Noboru Hara, +4

Cancer Letters

Molecular PharmacologyAndrogen ReceptorEndocrine-related CancerBiochemistryMedicine +9

External Validation of the UCSF-CAPRA (University of California, San Francisco, Cancer of the Prostate Risk Assessment) in Japanese Patients Receiving Radical Prostatectomy

Fumio Ishizaki, Md. Araful Hoque, Tsutomu Nishiyama, +8

Japanese Journal of Clinical Oncology